Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. APEX Biologix, LLC
483
•APEX Biologix, LLC•September 1, 2022

FDA 483 - APEX Biologix, LLC - September 01, 2022

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

An FDA inspection of APEX Biologix, LLC, a biological medical device manufacturer in Woods Cross, UT, revealed significant deficiencies in the firm's quality system. The inspection cited inadequate document control procedures, specifically concerning the review and approval of documents. Additionally, the firm's complaint handling procedures were found to be insufficiently established, leading to concerns about uniform and timely complaint processing.

Company
APEX Biologix, LLC
Inspection Date
September 1, 2022
Product Type
Device
Office
Denver District Office
Person
  • Creighton T. Tuzon
Open in Dashboard

ID · 08c8ce96-5448-489d-b66a-faa6e6fd7f70

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.